Premium
Plasma hydrogen sulfide: A biomarker of Alzheimer's disease and related dementias
Author(s) -
Disbrow Elizabeth,
Stokes Karen Y.,
Ledbetter Christina,
Patterson James,
Kelley Roger,
Pardue Sibile,
Reekes Tyler,
Larmeu Lana,
Batra Vinita,
Yuan Shuai,
Cvek Urska,
Trutschl Marjan,
Kilgore Phillip,
Alexander J. Steven,
Kevil Christopher G.
Publication year - 2021
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1002/alz.12305
Subject(s) - dementia , biomarker , disease , medicine , alzheimer's disease , vascular dementia , bioinformatics , biochemistry , biology
While heart disease remains a common cause of mortality, cerebrovascular disease also increases with age, and has been implicated in Alzheimer's disease and related dementias (ADRD). We have described hydrogen sulfide (H 2 S), a signaling molecule important in vascular homeostasis, as a biomarker of cardiovascular disease. We hypothesize that plasma H 2 S and its metabolites also relate to vascular and cognitive dysfunction in ADRD. We used analytical biochemical methods to measure plasma H 2 S metabolites and MRI to evaluate indicators of microvascular disease in ADRD. Levels of total H 2 S and specific metabolites were increased in ADRD versus controls. Cognition and microvascular disease indices were correlated with H 2 S levels. Total plasma sulfide was the strongest indicator of ADRD, and partially drove the relationship between cognitive dysfunction and white matter lesion volume, an indicator of microvascular disease. Our findings show that H 2 S is dysregulated in dementia, providing a potential biomarker for diagnosis and intervention.